Dear John,

Earlier today, Vinay Prasad was announced as the new director of the Food and Drug Administration center that oversees vaccine regulation and gene therapies.

Learn about these changes and more at event on May 29 providing a closer look at the FDA's first 100 days under the second Trump administration.

Today's Featured Articles

Eligibility Assistance Increases Insurance Enrollment Within Community Health Centers But Not At The State Level

Leighton Ku et al.

Drug Overdose Deaths Are Finally Slowing -- Medicaid Cuts Would Undermine That Progress

Carole Johnson et al.

part of our Health Policy At A Crossroads series

How Massachusetts’s New Health Care Reform Takes Aim at Private Equity

Nathan Hostert et al.

More on Community Health Centers

Policy Strategies To Propel Community Health Centers Into Value-Based Payment

Hope Glassberg et al. (March 2025)

CBO Score For The Bipartisan Primary Care And Health Workforce Act Recognizes The Value Of Primary Care Health Investments

Leighton Ku and Sara Rosenbaum (March 2024)

As They Await Congressional Action, Community Health Centers Are Facing A Perfect Storm

Basim Khan and Sara Rosenbaum (October 2023)

Health Affairs Branded Post:

Safe Delivery: Vital Solutions for Improving Maternal Health

Jacquelyn Caglia

Sponsored by Merck for Mothers

Eric Topol on the Science of Super-Aging and Longevity

Health Affairs' Senior Deputy Editor Rob Lott interviews Eric Topol, Executive Vice President of Scripps Research, on his new book, Super Agers, which provides an evidence-based approach on extending healthy lifespans.

FDA’s First 100 Days Under the Second Trump Administration

Join Health Affairs on May 29 for an exclusive Insider virtual event exploring the changes at the FDA under the first 100 days of the second Donald Trump administration with moderator Rachel Sachs and panelists Richard Hughes IV and Arti Rai.

Become an Insider for $180 annually to join us.